These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 23697247)
41. Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections. Saeliw P; Preechawai P; Aui-aree N J Med Assoc Thai; 2010 Oct; 93(10):1200-4. PubMed ID: 20973324 [TBL] [Abstract][Full Text] [Related]
42. Botulinum toxin for the treatment of essential blepharospasm. Shore JW; Leone CR; O'Connor PS; Neuhaus RW; Arnold AC Ophthalmic Surg; 1986 Nov; 17(11):747-53. PubMed ID: 3808585 [TBL] [Abstract][Full Text] [Related]
43. Life satisfaction of two-year post-stroke survivors: effects of socio-economic factors, motor impairment, Newcastle stroke-specific quality of life measure and World Health Organization quality of life: bref of informal caregivers in Luxembourg and a rural area in Portugal. Baumann M; Lurbe K; Leandro ME; Chau N Cerebrovasc Dis; 2012; 33(3):219-30. PubMed ID: 22261643 [TBL] [Abstract][Full Text] [Related]
44. AAN Updates Guidelines on the Uses of Botulinum Neurotoxin. Wilkes J Am Fam Physician; 2017 Feb; 95(3):198-199. PubMed ID: 28145664 [No Abstract] [Full Text] [Related]
45. Gender differences in benign essential blepharospasm. Lee MS; Johnson M; Harrison AR Ophthalmic Plast Reconstr Surg; 2012; 28(3):169-70. PubMed ID: 22460669 [TBL] [Abstract][Full Text] [Related]
47. Asymmetric blepharospasm with bilateral curtain sign. de Souza A; Bhonsle SK Eur J Neurol; 2012 Dec; 19(12):e141-2. PubMed ID: 23157244 [No Abstract] [Full Text] [Related]
48. Blepharospasm in a patient with pontine capillary telangiectasia. Gilbert AL; Dillon WP; Horton JC Ophthalmic Plast Reconstr Surg; 2012; 28(4):e92-3. PubMed ID: 22082598 [TBL] [Abstract][Full Text] [Related]
49. A new botulinum toxin potentially bioequivalent to onabotulinumtoxinA: are there any differences at all? Yang GH; Jung HH Dermatol Surg; 2013 Jan; 39(1 Pt 2):165-70. PubMed ID: 23301820 [No Abstract] [Full Text] [Related]
50. Promotion of cosmetic botulinum toxin A frowned upon. Larkin M Lancet; 2002 Sep; 360(9337):929. PubMed ID: 12354481 [No Abstract] [Full Text] [Related]
51. Prevalence, indications and demographic characteristics of Botulinum neurotoxin use in a tertiary oculoplastic centre. De Silva I; Lim C; Thomas M; Berry-Brincat A; Sampath R; Burns J Eye (Lond); 2022 Jul; 36(7):1409-1411. PubMed ID: 34183791 [TBL] [Abstract][Full Text] [Related]
53. Protective Effect of Blepharospasm on the Anterior Segment of the Eye. Biuk D; Vinković M; Barać J; Biuk E; Zelić Z; Matić S Acta Clin Croat; 2018 Mar; 57(1):130-133. PubMed ID: 30256021 [TBL] [Abstract][Full Text] [Related]
54. Health-related quality of life in blepharospasm and hemifacial spasm. Tan EK; Seah A Arch Ophthalmol; 2007 Aug; 125(8):1141; author reply 1141. PubMed ID: 17698774 [No Abstract] [Full Text] [Related]
55. An Exploratory, Randomized, Double-Blind Clinical Trial of Dipraglurant for Blepharospasm. Kilic-Berkmen G; Kim H; Chen D; Yeo CI; Dinasarapu AR; Scorr LM; Yeo WH; Peterson DA; Williams H; Ruby A; Mills R; Jinnah HA Mov Disord; 2024 Apr; 39(4):738-745. PubMed ID: 38310362 [TBL] [Abstract][Full Text] [Related]
56. Twelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation. Emoto Y; Emoto H; Oishi E; Hikita S; Wakakura M Drug Healthc Patient Saf; 2011; 3():9-14. PubMed ID: 21753898 [TBL] [Abstract][Full Text] [Related]
57. Role of GABAergic System in Blepharospasm. Suzuki Y; Ishii K; Kiyosawa M J Neuroophthalmol; 2016 Sep; 36(3):349-50. PubMed ID: 27533531 [No Abstract] [Full Text] [Related]
58. Role of GABAergic System in Blepharospasm: Response. Evinger C; Digre K J Neuroophthalmol; 2016 Sep; 36(3):350-2. PubMed ID: 27533532 [No Abstract] [Full Text] [Related]